Grace Sahaya Vidhubala Elangovan

  • Citations Per Year
Learn More
BACKGROUND Adherence to oral therapy over a long period is important for optimal outcomes in chronic myeloid leukemia (CML). METHODS Patients in the chronic phase of CML (taking imatinib for ≥ 6 months) were assessed by the 8-item Morisky Medication Adherence Scale and European Organisation for Research and Treatment of Cancer Quality of Life (QoL)(More)
  • 1